Locasalen 0,02 % - 3 % Salbe

Valsts: Beļģija

Valoda: vācu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
01-07-2005

Aktīvā sastāvdaļa:

Flumetasone Pivalate; Salicylsäure

Pieejams no:

Amdipharm

ATĶ kods:

D07XB01

SNN (starptautisko nepatentēto nosaukumu):

Flumetasone Pivalate; Salicylic Acid

Deva:

0,02 % - 3 %

Zāļu forma:

Salbe

Kompozīcija:

Flumetasone Pivalate 0.2 mg/g; Salicylsäure 30 mg/g

Ievadīšanas:

Anwendung auf der Haut

Ārstniecības joma:

Flumetasone

Produktu pārskats:

CTI-code: 051073-01 - Packmaß: 15 g - Vermarktung status: NO - FMD-code: 05060337262156 - CNK-code: 0053868 - Lieferung-Modus: Auf ärztliches Rezept

Autorizācija statuss:

Nicht kommerzialisiert

Lietošanas instrukcija

                                AMDIPHARM
Product Name
Locasalen Ointment 15g
PIP Code
BE 751-0290
Market
Belgium
Change Request No.
N/A
Drawing No.
FM09 261551-03
Component Type
Leaflet
Site Technical Code
Famar Pharma 335
Site Article No.
261551-03
Site Edge Code/R Bar
N/A
Point of Sale Code
N/A
Scale
100%
Colours (1)
PMS Black
Originated on
20/04/2006
Originated by
Roy Greenbrook
Originated at
ARK
Proof Status
P3 / M3
Amended by
Roy Greenbrook
Date Completed
16/05/2006
PROOFREADER’S CHECK
Accept Artwork ________ Reject Artwork _________
Signature_______________________________________
Date___________________________________________
(Note:- No Proofreader’s signature needed on approved
PDFs from customer.)
LOCAL MARKET REGULATORY SIGN OFF
Confirmation that this artwork has been approved, the text
content is correct. This component conforms with the Local
Market Regulatory requirements.
Accept Artwork ________ Reject Artwork _________
Signature_______________________________________
Name__________________________________________
Date___________________________________________
AMDIPHARM REGULATORY SIGN OFF
Confirmation that this artwork has been approved, the text
content is correct. This component conforms with the
Amdipharm Regulatory requirements.
Accept Artwork ________ Reject Artwork _________
Signature_______________________________________
Name__________________________________________
Date___________________________________________
MARKETING APPROVED FOR PRINTING SIGN OFF
Confirmation that this artwork has been approved for
printing and the text content is correct.
Accept Artwork ________ Reject Artwork _________
Signature_______________________________________
Name__________________________________________
Date___________________________________________
PRINT SUPPLIER INSTRUCTIONS
1.
The design and text shown on the artwork are the copyright of the
Requisitioning Customer.
2.
Artwork text and content must not be reset, remade, amended or
altered.
The only exceptions allowed are:
a) to items where you are requested to add an EAN bar
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija franču 01-07-2005
Produkta apraksts Produkta apraksts franču 25-11-2020
Lietošanas instrukcija Lietošanas instrukcija holandiešu 01-07-2005
Produkta apraksts Produkta apraksts holandiešu 25-11-2020